Skip to Main Content

Paper Details

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.
J Exp Med
8
2023
Author NameAffiliation
Rosalba LeporeBasel University Hospital and University of Basel
Rosalba LeporeBasel University Hospital
Rosalba Lepore
Rosalba Lepore
Torsten SchwedeUniversity of Basel
Torsten Schwede
Matthew H PorteusStanford University
  • 1 - 7

Datasets

Release 1.2